Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

763.43 -1.28 (-0.17%)
Streaming Delayed Price Updated: 3:28 PM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Eli Lilly’s Oral Drug Delivers Significant Weight Loss In Late-Stage Study
Via Stocktwits
Viking Therapeutics: What's Next?
Viking's 40% crash over fixable dosing issues ignores its best-in-class 12.2% oral weight loss and Phase 3 momentum. 
Via The Motley Fool
The Great Rebalancing: Sector Rotation Signals a Shifting Market Landscape
The stock market is currently undergoing a significant rebalancing act, as investors strategically shift their capital from one sector to another in anticipation of evolving economic conditions. This... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
When AI Execs Say the Market Looks Bubbly
Market chatter about the frothiness of the AI market seems to be picking up as OpenAI CEO Sam Altman claims that he too sees a bubble forming. 
Via The Motley Fool
Topics Artificial Intelligence
Immuneering Inks Supply Agreement With Eli Lilly For Latter’s Investigational Cancer Therapy: Retail Looks To Buy The Stock On Dips
Via Stocktwits
This Is What Whales Are Betting On Eli Lilly
 
Via Benzinga
Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts
Powell’s dovish Jackson Hole remarks signal that the Fed could cut rates as early as September, with markets now pricing an 80% chance of a 25 bps cut. 
Via MarketBeat
Topics ETFs Economy
Immuneering Announces Clinical Supply Agreement with Lilly to Evaluate Atebimetinib in Combination with Olomorasib
From Immuneering Corporation
Via GlobeNewswire
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Growth stocks are dominating the S&P 500, pushing the index's dividend yield to a 25-year low. 
Via The Motley Fool
Topics ETFs Stocks
2 Biotech Stocks That Could Soar 21% and 245% According to Wall Street's Top Analysts
These companies aren't performing as badly as their stock-market performances this year suggest. 
Via The Motley Fool
The Best Stocks to Invest $50,000 in Right Now
There are four names on this list, but the last one may come as a surprise. 
Via The Motley Fool
Topics Artificial Intelligence
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Incorporating top stocks from a variety of sectors can be an effective way to balance out an investment portfolio. 
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Investors looking to double down on mega cap stocks like the "Ten Titans" may want to take a closer look at this low-cost ETF. 
Via The Motley Fool
Topics ETFs Stocks
Warren Buffett Makes a Big Buy
Berkshire Hathaway bought $1.6 billion of United Health stock in Q2. Inflation may be ticking higher after all. 
Via The Motley Fool
Topics Economy
Options Corner: Embattled Drug Maker Novo Nordisk May Offer Speculators A Quick Profit-Scalping Opportunity
Although Novo Nordisk has been struggling for over a year, the relative discount may attract bullish speculators to NVO stock. 
Via Benzinga
$1000 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Here's Why Shares in Viking Therapeutics Crashed This Week
The phase 2 trial results for its key drug didn't pan out quite as planned. 
Via The Motley Fool
Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried?
There are some reasons to be worried; there are also reasons to be optimistic. 
Via The Motley Fool
Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy.
The tariffs will impact products imported from Europe, the Trump administration said late Thursday. 
Via Investor's Business Daily
Topics ETFs Government Intellectual Property
J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs
Johnson & Johnson (NYSE: JNJ) is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing operations. This move comes in response to potential drug import tariffs... 
Via Benzinga
Topics Government World Trade
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets
The race inside the weight loss industry is ramping up, leaving investors with three names to choose from in how they want to play this theme. 
Via MarketBeat
Is Beaten-Down Viking Therapeutics Stock a Buy on the Dip?
A disappointing result for its oral obesity candidate hammered the stock price. 
Via The Motley Fool
Here's Why Viking Therapeutics Bounced Back Today
Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data were disappointing. 
Via The Motley Fool
Under Pressure: Palantir and Viking Therapeutics Face Investor Scrutiny
The financial markets are a dynamic arena where fortunes can shift rapidly, and the past week has seen two prominent companies, Palantir Technologies Inc. (NYSE: PLTR) and Viking Therapeutics (NASDAQ:... 
Via MarketMinute
Topics Artificial Intelligence
Novo Nordisk Freezes Hiring As Wegovy Faces Copycats
Novo Nordisk may pursue layoffs as its new CEO focuses on efficiency while facing intensifying obesity drug competition. 
Via Benzinga
Topics Workforce
Is the Vanguard Dividend Appreciation ETF a Buy Now?
This stalwart ETF offers a little bit of everything and could outperform the S&P 500 if the Magnificent Seven stocks tumble. 
Via The Motley Fool
Topics ETFs Stocks
One of the Best Stocks to Buy Now?
I ranked Eli Lilly as one of the best stocks to buy starting in 2025. 
Via The Motley Fool
What's Going on With Eli Lilly Stock?
The pharma company is gaining investor attention due to increasingly popular products. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.